CoChat

Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis

HOMMA, SAKAE, AZUMA, ARATA, TANIGUCHI, HIROYUKI, OGURA, TAKASHI, MOCHIDUKI, YOSHIRO, SUGIYAMA, YUKIHIKO, NAKATA, KOICHIRO, YOSHIMURA, KUNIHIKO, TAKEUCHI, MASAHIRO, KUDOH, SHOJI, THE JAPAN NAC CLINICAL STUDY GROUP · 2012 · Respirology
Cited by 127

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Background and objective: Idiopathic pulmonary fibrosis (IPF) is a fatal disorder for which there are currently no specific or effective medical treatments. A multicentre, prospective, randomized, controlled clinical trial was conducted to assess the efficacy of inhaled N‐acetylcysteine (NAC) monotherapy in Japanese patients with early stage IPF. Methods: Eligible patients had well‐defined IPF of mild‐to‐moderate severity, with no desaturation on exercise. Of 100 patients screened, 76 were randomly assigned to an NAC treatment group (group A; n = 38) that received 352.4 mg of NAC by inhalation twice daily or to a control group (group B; n = 38) that received no therapy. The primary endpoint was the change from baseline in forced vital capacity (FVC) at 48 weeks. Results: There were no significant overall differences in the change in FVC between groups A and B. Post hoc exploratory analyses showed that NAC therapy was associated with stability of FVC in (i) a subset of patients with initial FVC <95% of predicted (n = 49; difference in FVC decline 0.12 L; P = 0.02) and (ii) in patients with initial diffusing capacity of carbon monoxide <55% of predicted (n = 21; difference in FVC decline 0.17 L; P = 0.009). Conclusions: These findings indicate that NAC monotherapy may have some beneficial effect in patients with early stage IPF. Further trials in more select IPF populations with progressive disease are required to prove the efficacy of inhaled NAC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1843.2012.02132.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 127

Metadata

Authors
HOMMA, S., AZUMA, A., TANIGUCHI, H., OGURA, T., MOCHIDUKI, Y., SUGIYAMA, Y., NAKATA, K., YOSHIMURA, K., TAKEUCHI, M., KUDOH, S., & THE JAPAN NAC CLINICAL STUDY GROUP
Venue
Respirology
Publisher
Wiley
Published
2012-03-23
Volume
17
Issue
3
Pages
467-477
ISSN
  • 1323-7799 (ISSN-L)
  • 1440-1843
OpenAlex
W1957975414
Cited by
127
References
4
FWCI
8.77
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1111/j.1440-1843.2012.02132.x
The paper
HOMMA, S., AZUMA, A., TANIGUCHI, H., OGURA, T., MOCHIDUKI, Y., SUGIYAMA, Y., NAKATA, K., YOSHIMURA, K., TAKEUCHI, M., KUDOH, S., & THE JAPAN NAC CLINICAL STUDY GROUP. (2012). Efficacy of inhaled N‐acetylcysteine monotherapy in patients with early stage idiopathic pulmonary fibrosis. Respirology. https://doi.org/10.1111/j.1440-1843.2012.02132.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.